Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Clinical trial NCT06331312 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06331312
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2028-05-08
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.